Attendees will
*Understand when, where and how Comparative Effectiveness Research should be factored into a drug manufacturer overall market access strategy
*Learn how to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
*Examine how to use HTA to create payer evidence: The role of postapproval programs
*Learn key concepts that public and private payers are looking for: Think like and ACO to build quality partnerships
*Examine the evolution of generics and biosimilars: How their impact will shift the markets- Can Pharma benefit
*Gain insight from managed care organizations: Their role as Pointof- Care and how their determinations affect your bottom line
Attendees will
*Understand when, where and how Comparative Effectiveness Research should be factored into a drug manufacturer’s overall market access strategy
*Learn how to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
*Examine how to use HTA to create payer evidence: The role of postapproval programs
*Learn key concepts that public and private payers are looking for: Think like and ACO to build quality partnerships
*Examine the evolution of generics and biosimilars: How their impact will shift the markets- Can Pharma benefit
*Gain insight from managed care organizations: Their role as Pointof- Care and how their determinations affect your bottom line
Attendees will
*Understand when, where and how Comparative Effectiveness Research should be factored into a drug manufacturer overall market access strategy
*Learn how to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
*Examine how to use HTA to create payer evidence: The role of postapproval programs
*Learn key concepts that public and private payers are looking for: Think like and ACO to build quality partnerships
*Examine the evolution of generics and biosimilars: How their impact will shift the markets- Can Pharma benefit
*Gain insight from managed care organizations: Their role as Pointof- Care and how their determinations affect your bottom line will be held in Boston,United States on date 2015-03-25
Deadline for abstracts/proposals : 23rd March 2015